Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...

Keith Largay joins Bain Capital from JLL, where he spent 14 years and most recently served as co-head of its Chicago office.

Bain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.

TOKYO & BOSTON--(BUSINESS WIRE)--Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation ...

Investment to accelerate Milacron’s growth and strengthen its position as a global leader in highly engineered plastic processing solutions. Milacron’s comprehensive suite of equipment ...

Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...

Tanabe Pharma focuses on therapeutic areas such as immunology and inflammation, vaccines, diabetes, and central nervous ...

Wells Fargo analyst Finian O’Shea maintained a Buy rating on Bain Capital Specialty Finance (BCSF – Research Report) today and set a price ...

Bain Capital is closing in on its next big target struggling with too much debt – the country’s second-largest hospital operator Healthscope.